New Antituberculosis Drugs: From Clinical Trial to Programmatic Use
Abstract
Share and Cite
Gualano, G.; Capone, S.; Matteelli, A.; Palmieri, F. New Antituberculosis Drugs: From Clinical Trial to Programmatic Use. Infect. Dis. Rep. 2016, 8, 6569. https://doi.org/10.4081/idr.2016.6569
Gualano G, Capone S, Matteelli A, Palmieri F. New Antituberculosis Drugs: From Clinical Trial to Programmatic Use. Infectious Disease Reports. 2016; 8(2):6569. https://doi.org/10.4081/idr.2016.6569
Chicago/Turabian StyleGualano, Gina, Susanna Capone, Alberto Matteelli, and Fabrizio Palmieri. 2016. "New Antituberculosis Drugs: From Clinical Trial to Programmatic Use" Infectious Disease Reports 8, no. 2: 6569. https://doi.org/10.4081/idr.2016.6569